













A rare cause of chronic diarrhoea: a diagnosis to keep in mind
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A 61-year-old male patient, who had undergone sur-
gery for a perforated small bowel ulcer two weeks 
earlier, reported for an outpatient visit to the gastroen-
terologist (TS). The patient presented with diarrhoea, 
weight loss, and weakness. 
He had suffered from watery diarrhoea, with 20 to 30 
bowel movements daily, for five years. Despite having 
visited many different specialists, his problems remained 
unresolved. Common causes of diarrhoea were ex-
cluded, including bacterial infection, parasites, colorectal 
cancer, inflammatory bowel diseases, and celiac disease. 
Colonoscopy with biopsy (2×), computed tomography 
(CT) of the abdomen (1×), and ultrasonography of the 
abdomen (3×) were performed and revealed no abnor-
mality. Meanwhile, the patient lost 30 kg and was so 
weak that he could not even walk. His medical history 
also included severe reflux oesophagitis and duodenal 
peptic ulcer, with good response to typical treatment 
4 years before. His family history was unremarkable. 
Clinical examination revealed mild–severe general 
status, cachexia, paleness, and tachycardia (110 bpm). 
Standard laboratory tests showed mild anaemia, hypo-
proteinaemia, and dyselectrolitaemia. Results of other 
blood tests were within normal ranges. 
According to the clinical presentation, gastrinoma 
was suspected, and high doses of oral esomeprazole 
(160 mg daily) were administered. Rapid improvement 
of symptoms with cessation of diarrhoea was achieved. 
Gastroscopy revealed thickening of gastric folds (Fig. 1). 
Positron emission tomography (PET/CT) with [68Ga]
Ga-DOTATATE demonstrated a 10-mm soft tissue le-
sion with increased somatostatin receptor expression 
located close to the duodenum (Fig. 2). This lesion was 
visualized as an abnormal lymph node (12.5 mm) in 
the hepatoduodenal ligament during endoscopic ultra-
sound (Fig. 3). The patient also had a slightly increased 
level of gastrin (190 pg/mL; normal level 100 pg/mL). 
The patient underwent surgical treatment, and the 
abnormal lymph node was removed. Histopathological 
examination revealed typical morphological and im-
munohistochemical features of a well-differentiated 
neuroendocrine tumour. The patient has remained 
symptom free during the 4.5 years since surgery, with 
a diagnosis of primary lymph node gastrinoma or oc-
cult primary gastrinoma with lymph node metastases. 
Gastrinoma is a gastrin-producing neuroendocrine tu-
mour that triggers hypersecretion of hydrochloric acid [1]. 
Most of these tumours arise in the so-called “gastrinoma 
triangle”, delineated by the second and third portions of 
the duodenum, the head and neck of the pancreas, and 
the junction of the cystic and common bile ducts [1]. These 
tumours can also rarely occur in the stomach, lymph 
nodes, liver, bile duct, ovary, and heart [1]. The existence 
of true primary lymph node gastrinoma is still an area 
of debate [2]. What is of special importance is that with 
Figure 1. Endoscopy showing thickening of the gastric folds 
(an endoscopic feature of gastrinoma)
Krzysztof Dąbkowski PhD MD, Department of Gastroenterology, Pomeranian Medical University, Unii Lubelskiej 1, 71–252 Szczecin,  
tel/fax:+48 914253211; e-mail: dabkowskikrzysztof@wp.pl
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles  
and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
188












somatostatin receptor targeting peptides are the mo-
dalities used for location diagnostics of the tumour 
[1,5]. In our case, taking into account the typical clinical 
course, despite only slightly elevated levels of gastrin, 
the attending physician referred the patient for [68Ga]
Ga-DOTATATE PET/CT, which has a sensitivity, specific-
ity, and diagnostic accuracy in gastro-entero-pancreatic 
neuroendocrine tumours reaching 90% [5]. This imag-
ing showed the exact location of the tumour and paved 
the way for a correct diagnosis and effective treatment. 
Our patient had typical clinical manifestations of gastrino-
ma, yet despite many gastroenterological appointments, 
the diagnosis was not established for a long time. During 
this delay, the patient experienced malabsorption and 
cachexia. For this reason, we believe that it is important 
to remind clinicians that one cause of diarrhoea is a gas-
trin-producing tumour. We emphasize that the gastrinoma 
location can be atypical and that normal or near-normal 
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suspicion of primary lymph node gastrinoma, the pos-
sibility of a metastatic lymph node of a gastrin-producing 
tumour in an occult location (microgastrinoma) should be 
considered in the differential diagnosis [3]. The diagnosis 
is thus rather one of exclusion after long-term observation 
[2] and an indication for careful exploration of the surgical 
field, including careful assessment of the gastrinoma tri-
angle and intraoperative sonography, transillumination, 
and duodenotomy [2, 3].
Typical clinical manifestations of gastrinoma include 
multiple peptic ulcers that are resistant to treatment and 
in atypical locations, chronic diarrhoea, oesophagitis, and 
weight loss [1]. The symptoms are often confused with 
those of other conditions such as indigestion, dyspepsia, 
or irritable bowel syndrome [4]. Moreover, the use of 
proton pump inhibitors typically leads to rapid symptom 
improvement, representing an effective method of symp-
tomatic treatment that carries the risk of masking the clini-
cal course and delaying proper diagnosis for years [1, 4].
From a practical point of view, gastrinoma biochemi-
cal diagnostics is based on gastrin serum level, which 
typically exceeds 10 times the normal concentration, 
although slightly elevated levels do not exclude the 
diagnosis [1]. CT, magnetic resonance, endoscopic 
ultrasound, and PET/CT with 68Ga-DOTA-conjugated 
Figure 3. Endoscopic ultrasound showing 12.5-mm lymph 
node in the hepato-duodenal ligament
Figure 2. [68Ga]Ga-DOTATATE PET/CT showing abnormal uptake near the pancreatic head and duodenal wall
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